$MILV Every stakeholder Ecomike has been hugely successful. The central figure that makes this all possible is going to make.... a lot of money seeing his patent application is the only one of its kind in the biotech world where his technology can pass the BLOOD BRAIN BARRIER (BBB). I'm pretty sure he now has cornered the market with his patent.
For instance, did you all know, that one of the major shareholders of CCA,LLC (who is R/M with $MILV , has 131 issued patents and 180 products sold world wide licensing his patents, most of which are based on Liposome technology, including the one assigned to CA,LLC who is soon to be MILV???
He, Dr. Michael W Fountain, was a major factor, patent inventor named in many patents held in the 1990s by a company called The Liposome Company.
In the year 2000 it was bought for $585 Million dollars, and the buyer was bought about a year later for 2 Billion dollars.
Shmp, a 20 year ongoing start up, with no revenue, rallied from .01 to .95 early this year based on news it had been awarded a single patent it only owns 1/2 of, for water recycling. It hit a $300 Mil dollar market cap and still has no revenue, trading .08 to .10 lately.
MILV is trading at .0032 to .0036 with a smaller float and no debt and no share printing even possible.
290 Mil share MILV float.
Fountain has 131 issued patents, Univ of Penn has 1032 patent applications pending and CCA, LLC, who is merging with MILV has a contract with the Univ of Penn, which is according to 2016 fillings based on solving and repair brain trauma with Fountain Liposomes.
News 
Market Data 
Discover 
